Health Experts Address Barriers to Accessing PCSK9 Therapies in ASCVD A recent panel discussion has highlighted significant barriers that hinder the utilization of PCSK9-targeting therapies in the management of atherosclerotic cardiovascular disease (ASCVD). Despite... Editorial23 December, 2025